Immune checkpoint inhibitor-associated myocarditis: a novel risk score
John R. Power(UC San Diego Health System), Anju Nohria(Mass General Brigham), Guillaume Bailly(Hôpital Lariboisière), Lorenz Lehmann(German Cancer Research Center), Benay Özbay(University of Pittsburgh), Pedro Moliner(Hospital Universitari Germans Trias i Pujol), Vlad G. Zaha(Southwestern Medical Center), Michel Obéid(University Hospital of Lausanne), Richard K. Cheng(University of Washington Medical Center), Giovanni Peretto(Vita-Salute San Raffaele University), Isik Turker, Roberta Florido(University of Utah), Alan H. Baik(Gladstone Institutes), Joshua Levenson, Nahéma Issa(Bordeaux Population Health), Peter P. Rainer(Johns Hopkins University), Michal Laufer‐Perl(Tel Aviv University), Nicolas L. Palaskas(The University of Texas MD Anderson Cancer Center), Pierre‐Yves Courand(Université Claude Bernard Lyon 1), François Roubille(Centre Hospitalier Universitaire de Montpellier), Dimitri Arangalage, Han Zhu(Hainan Normal University), Danette Flint, Eve Cariou(Hôpital Rangueil), Stéphane Éderhy, Shanthini Mary Crusz(Barts Health NHS Trust), Anna Narezkina(University of California San Diego), Jennifer Cautela, Adrien Procureur(Sorbonne Université), Shahneen Sandhu(Peter MacCallum Cancer Centre), Charlotte Fenioux, Darryl P. Leong(Hamilton Health Sciences), Charles Dolladille(Inserm), Salim S. Hayek(Emory University), Aarti Asnani, Yuichi Tamura(Mita Hospital), Nausheen Akhter, Nicolas Piriou(Centre Hospitalier Universitaire de Besançon), Yan Liu(Shanghai Jiao Tong University), Joachim Alexandre(Government of the United States of America), Lucie Heinzerling(LMU Klinikum), Assié Eslami(Université Paris Cité), Yen-Chou Chen(University of California, San Francisco), Seyed Ebrahim Kassaian(Tehran University of Medical Sciences), Stephen M Ewer(University of Wisconsin–Madison), Sanjeev Francis, Elizabeth M Gaughan(University of Virginia), Douglas B. Johnson(Vanderbilt University Medical Center), Wei Ting Chan(Chi Mei Medical Center), Lauren A. Baldassarre(Yale University)
Cited by 34
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
|Nature Reviews Clinical Oncology|2019|2.2k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k